Reading...
Play button
Play button
Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
7 Cards in this Set
- Front
- Back
|
cyclic regimen for woman with uterus
|
Cyclic therapy:
0.3mg/d CEE or equivalent estrogen and progestin 10-14 days/month Cyclic progestin = MPA 5mg/d or norethindrone 2.5 mg/d or norgestrel 0.15mg/d |
|
|
WHI prempro study- what was being tested?
outcomes? (3) |
CEE 0.625mg/MPA 2.5mg QD or pbo
cancer- increase in breast CHD** primary outcome- ppl thought prempro could decrease CHD but there were early instances of CHD + stroke later on fracture risk |
|
|
WHI study
|
STOPPED BECAUSE OF BREAST CANCER
ALSO INCREASED RISK OF DEMENTIA |
|
|
ARR in WHI
|
ARR for everythign in WHI was 1%
|
|
|
premarin only- outcomes
|
premarin only- no increase in CHD, no increase in breast cancer (improved actually)
but increase in everything else (stroke, DVT) |
|
|
onset of action for antidepressant usage
|
improvement in 1 week for venlafaxine, paroxetine, gaba
|
|
|
monitoring for HRT- 6 things at baseline
then how often after d you monitor everything? |
Pelvic and breast exam, Pap smear, mammography
lipid profile, BP Unopposed estrogen = endometrial evaluation to rule out hyperplasia or CA E + P = no endometrial evaluation required BP- eveyr 2 years eveyrthing else annually |
